Pure Global
NCT05266287

Changes in Microbiota and Quality of Life in IBS

Evaluating Changes in Microbiota Composition and Quality of Life in Irritable Bowel Syndrome: A Randomized, Controlled Trial
National University of Natural Medicine·ClinicalTrials.gov·dietary supplementNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
IBS - Irritable Bowel Syndrome
Drug/Device/Intervention
a supplement containing 2'-fucosyllactose (2'-FL)
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
National University of Natural Medicine
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2022
End date
Dec 31, 2022
Enrollment
50 participants
Primary outcome

F. Prausnitzii abundance

Summary

The primary research question to be addressed is: Does a 2'-FL-containing dietary supplement
 impact stool microbiota composition in adults with IBS? The primary measure for determining
 potential impacts of the 2'-FL-containing dietary supplement on stool microbiota composition
 is stool abundance of Faecalibacterium prausnitzii, a commensal intestinal bacteria.
 Additional measures related to determining potential impacts of the 2'-FL-containing dietary
 supplement on gut microbiota composition are stool levels of additional commensal intestinal
 bacteria and measures of intestinal microbial diversity.

ICD-10 classifications
Irritable bowel syndrome with predominant constipation [IBS-C]Irritable bowel syndromeIrritable bowel syndrome with predominant diarrhoea [IBS-D]Irritable bowel syndrome with mixed bowel habits [IBS-M]Other and unspecified irritable bowel syndrome
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05266287
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05266287 through Pure Global AI's free database. This phase not specified trial is sponsored by National University of Natural Medicine and is currently Not yet recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.